Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SBC vs GRNQ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBC Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

SBC Overall Winner 6-Pillar Tally: SBC 5 – 0 GRNQ (1 Tie) Matrix Metrics: SBC 7 – 3 GRNQ

As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over Greenpro Capital Corp. (GRNQ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBC carries a Unified Composite Score of 47.2/100 (HOLD) at $5.17 (9.0x Forward P/E, 39.9% operating margin), whereas GRNQ carries 50.0/100 (HOLD) at $7.55 (N/M Forward P/E, -78.7% operating margin).

  • Composite vs. Pillar Nuance: While GRNQ currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (39.9% vs. -78.7% operating margin) and revenue trajectory (+35.1% vs. +510.1% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SBC vs GRNQ
SBC NASDAQ Head-to-Head Winner
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.17
-7.68% 1D
Market Cap $574.4M
TTM Revenue $190M
Forward P/E 9.0x
Beta / 30D Vol 0.96β · 159% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 41.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.2 · SMA20: $5.54 · SMA50: $5.28
GRNQ NASDAQ
Greenpro Capital Corp. Common Stock
Services-Management Consulting Services
$7.55
+2.3% 1D
Market Cap $14.2M
TTM Revenue $2.8M
Forward P/E N/M
Beta / 30D Vol -0.65β · 57% Vol
Unified Composite Score
50.0 / 100 HOLD
Tech 49.0 Fund 41.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.7 · SMA20: $7.10 · SMA50: $8.14

6-Pillar Scorecard Institutional Category Breakdown (SBC 5 – 0 GRNQ)

Columns: Metric · SBC · GRNQ
1. Valuation Multiples SBC
Forward P/E 9.0x N/M
Trailing P/E 11.0x N/M
PEG Ratio 2.40x N/M
EV / Revenue 3.0x 4.9x
2. Growth & Scale SBC
Revenue Growth (YoY) +35.1% +510.1%
Earnings Growth (YoY) +22.4% +0.0%
TTM Revenue (USD) $190M $2.8M
Market Cap $574.4M $14.2M
3. Profitability & Quality SBC
Gross Margin 72.2% 52.9%
Operating Margin 39.9% -78.7%
Net Profit Margin 27.3% -127.3%
Return on Equity (ROE) 19.3% -15.9%
4. Balance Sheet & Cash Flow SBC
Cash Generation (TTM) $80M EBITDA -$2.5M
Cash Flow Margin 41.8% EBITDA Mgn -88.8%
Net Cash / Leverage $2.79 Book/Sh · 19.3% ROE -$458,443 Net Debt (0.00x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat SBC
OpEx & R&D Intensity 32.3% of Rev ($61M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SBC (7) vs GRNQ (3)
Institutional Metric SBC GRNQ Criterion Row Edge
Market Capitalization
Scale
$574.4M $14.2M Larger Scale SBC
Trailing P/E Ratio
Valuation
11.0x N/M Lower Multiple SBC
Forward P/E Ratio
Valuation
9.0x N/M Lower Multiple SBC
Revenue Growth (YoY)
Growth
+35.1% +510.1% Higher Growth GRNQ
Operating Margin (TTM)
Profitability
39.9% -78.7% Higher Margin SBC
Net Profit Margin
Profitability
27.3% -127.3% Higher Margin SBC
Return on Equity (ROE)
Capital Efficiency
19.3% -15.9% Higher ROE SBC
52-Week Range Position
Momentum
52% ($3–$7) 30% ($1–$23) Stronger Trend SBC
Beta / 30D Volatility
Risk Regime
0.96β · 159% Vol -0.65β · 57% Vol Lower Realized Risk GRNQ
Unified Institutional Score
Composite Signal
47.2 / 100 (HOLD) 50.0 / 100 (HOLD) Higher Composite GRNQ
Trailing 12M Revenue (USD)
Operating Scale
$190M $2.8M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
72.2% 52.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.40x PEG · 3.0x EV/Rev N/M PEG · 4.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$80M EBITDA ($2.79 Book/Sh · 19.3% ROE) -$2.5M (-$458,443 Net Debt (0.00x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GRNQ +14.73 pp
SBC: -9.14% · GRNQ: +5.59%
3M Horizon SBC +66.39 pp
SBC: +29.25% · GRNQ: -37.14%
6M Horizon GRNQ +271.96 pp
SBC: +80.14% · GRNQ: +352.1%
1Y Horizon GRNQ +293.38 pp
SBC: +63.61% · GRNQ: +356.99%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBC vs GRNQ. Trailing 12-month operating profitability (SBC 39.9% vs GRNQ -78.7%) and valuation multiples (SBC 9.0x vs GRNQ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SBC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$190M
Gross Margin72.2%
Op. Margin39.9%
ROE / Fwd P/E19.3% · 9.0x
GRNQ ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.8M
Gross Margin52.9%
Op. Margin-78.7%
ROE / Fwd P/E-15.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SBC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GRNQ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GRNQ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SBC Moat Profile High-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $574.4M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment 32.3% of Rev ($61M)
90D Engineering Disclosures 0 Published
GRNQ Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $14.2M market capitalization and -78.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SBC vs GRNQ Key Questions & Quantitative Answers

As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over Greenpro Capital Corp. (GRNQ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBC carries a Unified Composite Score of 47.2/100 (HOLD) at $5.17 (9.0x Forward P/E, 39.9% operating margin), whereas GRNQ carries 50.0/100 (HOLD) at $7.55 (N/M Forward P/E, -78.7% operating margin). Composite vs. Pillar Nuance: While GRNQ currently prints a higher short-term Unified Composite Score (50.0/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (39.9% vs. -78.7% operating margin) and revenue trajectory (+35.1% vs. +510.1% YoY).

SBC leads the Growth & Scale pillar: SBC posts +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin), compared with GRNQ at +510.1% YoY revenue growth and +0.0% YoY earnings growth on $2.8M TTM revenue (52.9% gross margin, -78.7% operating margin). On trailing 12-month operating scale, SBC generates $190M in USD-normalized revenue versus $2.8M for GRNQ. In operating R&D and SG&A reinvestment, SBC deploys 32.3% of Rev ($61M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GRNQ.

SBC screens cheaper on headline valuation multiples. SBC trades at 9.0x Forward P/E, 11.0x Trailing P/E, 2.40x PEG, and 3.0x EV/Revenue (41.8% EBITDA margin), whereas GRNQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 4.9x EV/Revenue (-88.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SBC (19.3% ROE) versus GRNQ (-15.9% ROE) capital efficiency.

In options market volatility and institutional positioning, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 159% Vol realized risk). By comparison, GRNQ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.65β · 57% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.